Greentree Hospit Financials

GHG

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2024 Currency USD FYE December

Financial Health Signals

Financial Profile 56/100

Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Greentree Hospit has an operating margin of 12.0%, meaning the company retains $12 of operating profit per $100 of revenue. This results in a moderate score of 60/100, indicating healthy but not exceptional operating efficiency. This is down from 20.6% the prior year.

Growth

Greentree Hospit's revenue declined 19.7% year-over-year, from $229.2M to $184.1M. This contraction results in a growth score of 0/100.

Leverage

100

Greentree Hospit carries a low D/E ratio of 0.18, meaning only $0.18 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Greentree Hospit's current ratio of 1.57 indicates adequate short-term liquidity, earning a score of 43/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

100

Greentree Hospit converts 21.9% of revenue into free cash flow ($40.2M). This strong cash generation earns a score of 100/100.

Returns

Greentree Hospit's ROE of 7.5% shows moderate profitability relative to equity, earning a score of 30/100. This is down from 18.7% the prior year.

Altman Z-Score Distress

0.59

Greentree Hospit scores 0.59, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Piotroski F-Score Neutral

4/9

Greentree Hospit passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

3.39x

For every $1 of reported earnings, Greentree Hospit generates $3.39 in operating cash flow ($51.2M OCF vs $15.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

25.7x

Greentree Hospit earns $25.7 in operating income for every $1 of interest expense ($22.2M vs $864K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

This page shows Greentree Hospit (GHG) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Export CSV

Key Financial Metrics

Revenue

$184.1M

YoY-19.7%

5Y CAGR+3.3%

Greentree Hospit generated $184.1M in revenue in fiscal year 2024. This represents a decrease of 19.7% from the prior year.

EBITDA

$36.2M

YoY-43.2%

5Y CAGR-14.3%

Greentree Hospit's EBITDA was $36.2M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 43.2% from the prior year.

Free Cash Flow

$40.2M

YoY-22.2%

5Y CAGR-1.4%

Greentree Hospit generated $40.2M in free cash flow in fiscal year 2024, representing cash available after capex. This represents a decrease of 22.2% from the prior year.

Net Income

$15.1M

YoY-60.3%

5Y CAGR-25.0%

Greentree Hospit reported $15.1M in net income in fiscal year 2024. This represents a decrease of 60.3% from the prior year.

EPS (Diluted)

N/A

Cash & Debt

$204.2M

YoY+89.3%

5Y CAGR+34.8%

Greentree Hospit held $204.2M in cash against $35.2M in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

N/A

Gross Margin

38.8%

YoY-3.0pp

5Y CAGR-30.2pp

Greentree Hospit's gross margin was 38.8% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 3.0 percentage points from the prior year.

Operating Margin

12.0%

YoY-8.6pp

5Y CAGR-34.2pp

Greentree Hospit's operating margin was 12.0% in fiscal year 2024, reflecting core business profitability. This is down 8.6 percentage points from the prior year.

Net Margin

8.2%

YoY-8.4pp

5Y CAGR-32.4pp

Greentree Hospit's net profit margin was 8.2% in fiscal year 2024, showing the share of revenue converted to profit. This is down 8.4 percentage points from the prior year.

Return on Equity

7.5%

YoY-11.1pp

5Y CAGR-16.3pp

Greentree Hospit's ROE was 7.5% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 11.1 percentage points from the prior year.

R&D Spending

N/A

Share Buybacks

$50K

YoY-98.2%

Greentree Hospit spent $50K on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 98.2% from the prior year.

Capital Expenditures

$10.9M

YoY-11.8%

5Y CAGR-18.7%

Greentree Hospit invested $10.9M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 11.8% from the prior year.

GHG Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$184.1M-19.7%	$229.2M+68.7%	$135.8M-28.2%	$189.3M+32.8%	$142.5M-9.1%	$156.8M
Cost of Revenue	$112.7M-15.5%	$133.4M+54.9%	$86.1M-15.7%	$102.2M+69.9%	$60.2M+23.6%	$48.7M
Gross Profit	$71.4M-25.5%	$95.8M+92.7%	$49.7M-42.9%	$87.1M+5.7%	$82.4M-23.8%	$108.2M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$25.0M-14.8%	$29.4M-3.9%	$30.6M-45.3%	$55.9M+111.3%	$26.4M-0.5%	$26.6M
Operating Income	$22.2M-53.1%	$47.3M+173.6%	-$64.2M-366.0%	$24.2M-50.6%	$48.9M-32.5%	$72.5M
Interest Expense	$864K-56.3%	$2.0M-46.2%	$3.7M+85.0%	$2.0M+275.4%	$530K+47.2%	$360K
Income Tax	$12.2M-27.1%	$16.7M+352.4%	-$6.6M-138.7%	$17.1M+0.9%	$16.9M-37.8%	$27.2M
Net Income	$15.1M-60.3%	$37.9M+168.4%	-$55.4M-400.7%	$18.4M-54.0%	$40.1M-37.0%	$63.6M
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'24	Q4'23	Q4'22	Q4'21	Q4'20	Q4'19	Q4'18
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A	N/A

GHG Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$677.8M-5.0%	$713.6M-3.4%	$738.9M+0.9%	$732.4M+16.7%	$627.6M+14.5%	$548.2M
Current Assets	$251.4M+9.7%	$229.1M-7.1%	$246.8M-14.1%	$287.4M+18.3%	$242.8M+33.6%	$181.7M
Cash & Equivalents	$204.2M+89.3%	$107.8M+16.7%	$92.4M+97.3%	$46.8M-50.0%	$93.7M+103.9%	$45.9M
Inventory	$943K-67.3%	$2.9M+789.0%	$324K-10.1%	$361K-38.2%	$583K+60.0%	$365K
Accounts Receivable	$13.7M-21.7%	$17.4M+4.2%	$16.7M+11.6%	$15.0M-3.6%	$15.6M+8.6%	$14.3M
Goodwill	$13.2M-47.2%	$24.9M+481.5%	$4.3M-75.5%	$17.5M+11.4%	$15.7M+2.5%	$15.3M
Total Liabilities	$473.3M-6.3%	$505.2M-3.4%	$523.0M+27.0%	$411.8M+45.6%	$282.8M+9.4%	$258.4M
Current Liabilities	$159.7M-15.5%	$189.0M+5.5%	$179.0M-8.7%	$196.1M+47.2%	$133.3M+16.7%	$114.2M
Long-Term Debt	$35.2M+337.9%	$8.0M-81.7%	$43.8M-7.6%	$47.4M	N/A	N/A
Total Equity	$199.8M-1.6%	$203.1M-3.0%	$209.4M-28.2%	$291.5M-9.6%	$322.3M+20.6%	$267.3M
Retained Earnings	-$62.8M+21.6%	-$80.0M-887.4%	-$8.1M-115.8%	$51.2M-41.4%	$87.4M+97.0%	$44.3M

Metric	Q4'24	Q4'23	Q4'22	Q4'21	Q4'20	Q4'19	Q4'18
Total Assets	$677.8M-5.0%	$713.6M-3.4%	$738.9M+0.9%	$732.4M+16.7%	$627.6M+14.5%	$548.2M+25.0%	$438.4M
Current Assets	$251.4M+9.7%	$229.1M-7.1%	$246.8M-14.1%	$287.4M+18.3%	$242.8M+33.6%	$181.7M-49.0%	$356.4M
Cash & Equivalents	$204.2M+89.3%	$107.8M+16.7%	$92.4M+97.3%	$46.8M-50.0%	$93.7M+103.9%	$45.9M-75.0%	$183.8M
Inventory	$943K-67.3%	$2.9M+789.0%	$324K-10.1%	$361K-38.2%	$583K+60.0%	$365K-1.6%	$371K
Accounts Receivable	$13.7M-21.7%	$17.4M+4.2%	$16.7M+11.6%	$15.0M-3.6%	$15.6M+8.6%	$14.3M+51.8%	$9.4M
Goodwill	$13.2M-47.2%	$24.9M+481.5%	$4.3M-75.5%	$17.5M+11.4%	$15.7M+2.5%	$15.3M+1745.1%	$831K
Total Liabilities	$473.3M-6.3%	$505.2M-3.4%	$523.0M+27.0%	$411.8M+45.6%	$282.8M+9.4%	$258.4M+54.3%	$167.4M
Current Liabilities	$159.7M-15.5%	$189.0M+5.5%	$179.0M-8.7%	$196.1M+47.2%	$133.3M+16.7%	$114.2M+16.2%	$98.2M
Long-Term Debt	$35.2M+337.9%	$8.0M-81.7%	$43.8M-7.6%	$47.4M	N/A	N/A	N/A
Total Equity	$199.8M-1.6%	$203.1M-3.0%	$209.4M-28.2%	$291.5M-9.6%	$322.3M+20.6%	$267.3M-0.9%	$269.8M
Retained Earnings	-$62.8M+21.6%	-$80.0M-887.4%	-$8.1M-115.8%	$51.2M-41.4%	$87.4M+97.0%	$44.3M-33.2%	$66.4M

GHG Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	$51.2M-20.2%	$64.1M+51.3%	$42.4M-25.2%	$56.6M+25.2%	$45.3M-38.7%	$73.8M
Capital Expenditures	$10.9M-11.8%	$12.4M+23.5%	$10.0M-81.3%	$53.6M+212.6%	$17.2M-44.0%	$30.6M
Free Cash Flow	$40.2M-22.2%	$51.7M+59.9%	$32.4M+970.8%	$3.0M-89.2%	$28.1M-34.9%	$43.2M
Investing Cash Flow	$47.3M+458.5%	-$13.2M-122.8%	$57.8M+139.7%	-$145.7M-752.1%	-$17.1M+90.2%	-$175.2M
Financing Cash Flow	$1.4M+103.4%	-$42.8M+13.7%	-$49.6M-223.6%	$40.1M+126.6%	$17.7M+158.1%	-$30.5M
Dividends Paid	$9.7M	N/A	$5.9M-88.2%	$50.3M	N/A	$32.6M
Share Buybacks	$50K-98.2%	$2.8M	N/A	N/A	N/A	N/A

Metric	Q4'24	Q4'23	Q4'22	Q4'21	Q4'20	Q4'19	Q4'18
Operating Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A

GHG Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	38.8%-3.0pp	41.8%+5.2pp	36.6%-9.4pp	46.0%-11.8pp	57.8%-11.2pp	69.0%
Operating Margin	12.0%-8.6pp	20.6%+67.9pp	-47.3%-60.1pp	12.8%-21.6pp	34.3%-11.9pp	46.2%
Net Margin	8.2%-8.4pp	16.6%+57.4pp	-40.8%-50.5pp	9.7%-18.4pp	28.1%-12.4pp	40.6%
Return on Equity	7.5%-11.1pp	18.7%	N/A	6.3%-6.1pp	12.4%-11.4pp	23.8%
Return on Assets	2.2%-3.1pp	5.3%+12.8pp	-7.5%-10.0pp	2.5%-3.9pp	6.4%-5.2pp	11.6%
Current Ratio	1.57+0.4	1.21-0.2	1.38-0.1	1.47-0.4	1.82+0.2	1.59
Debt-to-Equity	0.18+0.1	0.04-0.2	0.21+0.0	0.16-0.7	0.88-0.1	0.97
FCF Margin	21.9%-0.7pp	22.6%-1.3pp	23.8%+22.2pp	1.6%-18.1pp	19.7%-7.8pp	27.5%

Metric	Q4'24	Q4'23	Q4'22	Q4'21	Q4'20	Q4'19	Q4'18
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	1.57+0.4	1.21-0.2	1.38-0.1	1.47-0.4	1.82+0.2	1.59-2.0	3.63
Debt-to-Equity	0.18+0.1	0.04-0.2	0.21+0.0	0.16-0.7	0.88-0.1	0.97+0.3	0.62
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Civeo Corp Cda CVEO

$329.7M

Soho House & Co Inc SHCO

$1.8B

MCG

$1.3B

SONDER HOLDINGS INC SOND

$1.7M

MDJM LTD UOKA

$422K

Frequently Asked Questions

What is Greentree Hospit's annual revenue?

Greentree Hospit (GHG) reported $184.1M in total revenue for fiscal year 2024. This represents a -19.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Greentree Hospit's revenue growing?

Greentree Hospit (GHG) revenue declined by 19.7% year-over-year, from $229.2M to $184.1M in fiscal year 2024.

Is Greentree Hospit profitable?

Yes, Greentree Hospit (GHG) reported a net income of $15.1M in fiscal year 2024, with a net profit margin of 8.2%.

What is Greentree Hospit's EBITDA?

Greentree Hospit (GHG) had EBITDA of $36.2M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Greentree Hospit have?

As of fiscal year 2024, Greentree Hospit (GHG) had $204.2M in cash and equivalents against $35.2M in long-term debt.

What is Greentree Hospit's gross margin?

Greentree Hospit (GHG) had a gross margin of 38.8% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is Greentree Hospit's operating margin?

Greentree Hospit (GHG) had an operating margin of 12.0% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is Greentree Hospit's net profit margin?

Greentree Hospit (GHG) had a net profit margin of 8.2% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is Greentree Hospit's return on equity (ROE)?

Greentree Hospit (GHG) has a return on equity of 7.5% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is Greentree Hospit's free cash flow?

Greentree Hospit (GHG) generated $40.2M in free cash flow during fiscal year 2024. This represents a -22.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Greentree Hospit's operating cash flow?

Greentree Hospit (GHG) generated $51.2M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Greentree Hospit's total assets?

Greentree Hospit (GHG) had $677.8M in total assets as of fiscal year 2024, including both current and long-term assets.

What are Greentree Hospit's capital expenditures?

Greentree Hospit (GHG) invested $10.9M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

Does Greentree Hospit buy back shares?

Yes, Greentree Hospit (GHG) spent $50K on share buybacks during fiscal year 2024, returning capital to shareholders by reducing shares outstanding.

What is Greentree Hospit's current ratio?

Greentree Hospit (GHG) had a current ratio of 1.57 as of fiscal year 2024, which is generally considered healthy.

What is Greentree Hospit's debt-to-equity ratio?

Greentree Hospit (GHG) had a debt-to-equity ratio of 0.18 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Greentree Hospit's return on assets (ROA)?

Greentree Hospit (GHG) had a return on assets of 2.2% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Greentree Hospit's Altman Z-Score?

Greentree Hospit (GHG) has an Altman Z-Score of 0.59, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Greentree Hospit's Piotroski F-Score?

Greentree Hospit (GHG) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Greentree Hospit's earnings high quality?

Greentree Hospit (GHG) has an earnings quality ratio of 3.39x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Greentree Hospit cover its interest payments?

Greentree Hospit (GHG) has an interest coverage ratio of 25.7x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Greentree Hospit?

Greentree Hospit (GHG) scores 56 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.